NeoGenomics Inc. (NEO) Insider Trading

Last 12 months

Insiders sold $968k and bought nothing on the open market.

67% of the selling was scheduled in advance under 10b5-1 plans. Chief Accounting Officer Greg D Aunan sold $321k on Aug 4, 80% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2025.

Net open-market

−$968k

0 buys · 5 sales

Under a 10b5-1 plan

67%

of the value sold

Insiders who bought / sold

0 / 4

executives and directors

Last open-market buy

Aug 2025

Aug 6, 2025

Get an email when NEO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 4	Greg D Aunan Chief Accounting Officer	SoldNo plan	20,000	$16.07	$321k	80%	Form 4
Jun 15	Lynn A. Tetrault Director	Sold10b5-1 plan	5,307	$11.10	$59k	5.4%	Form 4
Jun 9	Lynn A. Tetrault Director	Sold10b5-1 plan	5,307	$11.29	$60k	5.1%	Form 4
Jan 20	Warren Stone Pres & Chief Operating Officer	Sold10b5-1 plan	22,128	$12.50	$277k	15%	Form 4
Nov 25, 2025	Alicia C Olivo EVP, GC & Business Development	Sold10b5-1 plan	20,916	$12.00	$251k	40%	Form 4
Oct 16, 2025	Alicia C Olivo EVP, GC & Business Development	Sold10b5-1 plan	4,918	$10.00	$49k	10%	Form 4
Aug 6, 2025	Jeffrey Scott Sherman Chief Financial Officer	Bought	20,000	$5.62	$112k	12%	Form 4
Aug 6, 2025	Anthony P. Zook Chief Executive Officer	Bought	17,900	$5.58	$100k	46%	Form 4
May 27, 2025	Michael Aaron Kelly Director	Bought	5,000	$7.60	$38k	16%	Form 4
May 12, 2025	Warren Stone Pres & Chief Operating Officer	Bought	5,700	$8.58	$49k	5.6%	Form 4
May 9, 2025	Lynn A. Tetrault Director	Bought	7,000	$8.14	$57k	11%	Form 4
May 7, 2025	Stephen M Kanovsky Director	Bought	4,000	$7.78	$31k	11%	Form 4
May 6, 2025	Anthony P. Zook Chief Executive Officer	Bought	18,900	$7.88	$149k	167%	Form 4
May 5, 2025	David Brian Perez Director	Bought	10,000	$7.63	$76k	46%	Form 4
May 5, 2025	Neil Gunn Director	Bought	4,510	$7.76	$35k	40%	Form 4
May 2, 2025	Jeffrey Scott Sherman Chief Financial Officer	Bought	20,000	$7.51	$150k	14%	Form 4
Nov 15, 2024	Alicia C Olivo General Counsel	Sold10b5-1 plan	5,175	$15.36	$79k	12%	Form 4

Aug 4No plan
Greg D Aunan
Chief Accounting Officer · sold 20,000 at $16.07
$321k
80% of stake
Jun 1510b5-1 plan
Lynn A. Tetrault
Director · sold 5,307 at $11.10
$59k
5.4% of stake
Jun 910b5-1 plan
Lynn A. Tetrault
Director · sold 5,307 at $11.29
$60k
5.1% of stake
Jan 2010b5-1 plan
Warren Stone
Pres & Chief Operating Officer · sold 22,128 at $12.50
$277k
15% of stake
Nov 25, 202510b5-1 plan
Alicia C Olivo
EVP, GC & Business Development · sold 20,916 at $12.00
$251k
40% of stake
Oct 16, 202510b5-1 plan
Alicia C Olivo
EVP, GC & Business Development · sold 4,918 at $10.00
$49k
10% of stake
Aug 6, 2025
Jeffrey Scott Sherman
Chief Financial Officer · bought 20,000 at $5.62
$112k
12% of stake
Aug 6, 2025
Anthony P. Zook
Chief Executive Officer · bought 17,900 at $5.58
$100k
46% of stake
May 27, 2025
Michael Aaron Kelly
Director · bought 5,000 at $7.60
$38k
16% of stake
May 12, 2025
Warren Stone
Pres & Chief Operating Officer · bought 5,700 at $8.58
$49k
5.6% of stake
May 9, 2025
Lynn A. Tetrault
Director · bought 7,000 at $8.14
$57k
11% of stake
May 7, 2025
Stephen M Kanovsky
Director · bought 4,000 at $7.78
$31k
11% of stake
May 6, 2025
Anthony P. Zook
Chief Executive Officer · bought 18,900 at $7.88
$149k
167% of stake
May 5, 2025
David Brian Perez
Director · bought 10,000 at $7.63
$76k
46% of stake
May 5, 2025
Neil Gunn
Director · bought 4,510 at $7.76
$35k
40% of stake
May 2, 2025
Jeffrey Scott Sherman
Chief Financial Officer · bought 20,000 at $7.51
$150k
14% of stake
Nov 15, 202410b5-1 plan
Alicia C Olivo
General Counsel · sold 5,175 at $15.36
$79k
12% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NEO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Testing Laboratories

ULSUl Solutions Inc.

NOTVInotiv Inc.

NRCNrc Health

MEDPMedpace Holdings Inc.

CRLCharles River Laboratories International, Inc.

INCYIncyte Corporation

MEGOnterris, Inc.

WLDNWilldan Group, Inc.

Spot a number that looks wrong? Check it in NEO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NEO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.